G1 Therapeutics Announces Upcoming Presentation at the 2024
G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting...
Source: globenewswire.com
Presentation Details News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Presentation Details. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Presentation Details Today - Breaking & Trending Today
G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology Meeting
G1 Therapeutics, Inc. announced that mature Phase 2 results describing the positive impact of trilaciclib administered in combination with the TROP2 antibody-drug conjugate sacituzumab govitecan on...
Source: marketscreener.com
CatalYm to Present Positive New Phase 2a Follow-up Data on GDF-15 Neutralizing Antibody Visugromab in Advanced NSCLC, Urothelial, and Hepatocellular Cancer at the 2024 ASCO Annual Meeting
Oral presentation in "Developmental Therapeutics-Immunotherapy" session on Sunday, June 2, 2024, at 11:30 AM CDT CatalYm today announced that positive new follow-up results from its ongoing "GDFATHER"
Source: finanznachrichten.de
CellFE Announces Presentations at Upcoming International Society of Gene & Cell Therapy (ISCT) 2024 Annual Meeting
/PRNewswire/ -- CellFE Inc., a cell engineering platform company with a novel microfluidic technology for non-viral cell therapy manufacturing, announced today...
Source: prnewswire.com
G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting
RESEARCH TRIANGLE PARK, N.C., May 23, 2024 -- G1 Therapeutics, Inc. , a commercial-stage oncology company, today announced that mature Phase 2 results describing the positive impact of trilaciclib...
Source: marketscreener.com